Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 4 Next >

Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies

Today 8:00 EST

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

December 15, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 08, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics

November 17, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference

November 05, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference

October 22, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025

October 14, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business

October 14, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook

October 14, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota

October 10, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the UBS Global Healthcare Conference

October 09, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

October 06, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

September 08, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

September 08, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

September 03, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

July 30, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

July 24, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

July 16, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook

July 16, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

June 10, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

May 28, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference

May 21, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 14, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson expands efforts to champion the nursing workforce globally

May 08, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference

April 28, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

April 16, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%

April 15, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q1 2025 Results

April 15, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference

April 07, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership

April 02, 2025

From Johnson & Johnson

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.